UT MD Anderson honors visionary leadership of Dr. Peter Pisters following retirement announcement; shares transition plans
The University of Texas MD Anderson Cancer Center today is recognizing the exceptional leadership of Peter WT Pisters, M.D., president, following his announced plan to retire from UT MD Anderson to focus on the next chapter of his career. The UT System Board of Regents and Chancellor John M. Zerwas, M.D., have named Jeffrey E. Lee, M.D., interim president, effective immediately. Pisters will work with Lee on a thoughtful transition through...
UT MD Anderson ranks No. 1 in the nation for cancer care for 12th year in a row
Ranking reflects commitment to excellence in evidence-based cancer care
Two specialties receive national rankings, and six procedures...
UT MD Anderson joins global consortium committed to eliminating cervical cancer
The University of Texas MD Anderson Cancer Center today announced it has joined a global consortium dedicated to accelerating the elimination...
ASCO: UT MD Anderson faculty honored as 2026 Special Award recipients
Sharon Giordano will receive the Gianni Bonadonna Breast Cancer Award for significant contributions to breast cancer care and research
Eduardo Vilar-Sanchez will receive the ASCO-American Cancer Society Cancer Prevention Award for his work to advance impactful cancer prevention research
In honor of their outstanding contributions to oncology, Sharon Giordano, M.D., chair of Breast Medical Oncology, and Eduardo Vilar-Sanchez, M.D...
UT MD Anderson names Albert Koong, M.D., Ph.D., chief scientific officer
The University of Texas MD Anderson Cancer Center today announced that Albert Koong, M.D., Ph.D., an internationally recognized physician-scientist...
CPRIT awards UT MD Anderson over $19 million for cancer research and faculty recruitment
The University of Texas MD Anderson Cancer Center today was awarded over $19 million from the Cancer Prevention and Research Institute of...
Novel CAR T cell therapy developed by UT MD Anderson researchers moves into clinical studies
The novel therapy targets CD94+ relapsed or refractory T/NK cell lymphomas
UT MD Anderson received Investigational New Drug clearance from the...
UT MD Anderson appoints Kim Slusser as chief nurse executive
The University of Texas MD Anderson Cancer Center today announced the appointment of Kim Slusser, Ph.D., R.N., as the institution’s inaugural...
UT MD Anderson establishes Center for Cellular Language Intelligence with $10 million gift from Peggy and Carl Sewell
The University of Texas MD Anderson Cancer Center today announced a $10 million gift from Peggy and Carl Sewell to...
AACR: Jennifer Wargo, M.D., elected Fellow of the AACR Academy
Jennifer Wargo, M.D., professor of Surgical Oncology and Genomic Medicine at The University of Texas MD Anderson...